VANCOUVER, April 4, 2018 /CNW/ - INVICTUS MD
STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC:
IVITF; FRA: 8IS1) is pleased to announce, on the heels of
kicking off construction on 40,000 sq. ft. of additional
cultivation space and appointing Rock & Roll Hall of Famer
Gene Simmons of KISS as Chief
Evangelist Officer, Invictus ranked fifth overall in share
appreciation among Canada's
Cannabis leaders for the first quarter of 2018 and was the overall
top performer last week, according to Mackie Research's The
Daily Extract - Weekend Edition - April
1, 2018 (source: Capitol IQ).
"With legislation on track to legalize adult use of cannabis by
the end of summer, Invictus, has a strong foundation and is well
positioned to take a stronghold in this multi-billion dollar
industry," said Dan Kriznic, Chairman and CEO of Invictus.
Founded in Vancouver, BC,
Invictus is a cannabis company that is dedicated to offering
high-quality, regulated cannabis for medical use and for adult use
as Canada marches towards full
legalization during 2018. The Company owns a platform of licensed
cannabis producers located throughout Canada who operate under the Access to
Cannabis for Medical Purposes Regulations (the "ACMPR"). The
Company's growers are supported by more than 250 acres of
production capacity and have total access to Invictus' team of
leading horticulturists, biochemists and project managers.
Invictus stands out among very few Canadian cannabis companies
that have declared dividends and is well-positioned to become one
of the leaders in the legal cannabis space – not just in
Canada but globally.
About Invictus
Invictus owns and operates cannabis companies in Canada with the vision of producing a variety
of high quality and low cost cannabis products and strains to the
global market place as regulations permit. Gene Simmons, music legend and media mogul,
conveys the vision of Invictus as the Chief Evangelist Officer.
Invictus operates two cannabis production sites under the Access
to Cannabis for Medical Purposes Regulations ("ACMPR") in
Canada and has over 95,000 square
feet of cannabis production capacity at the licensed production
sites. The Company's wholly owned subsidiary Acreage Pharms
Ltd. ("Acreage Pharms"), located in West-Central Alberta on
150 acres, has approximately 40,000 square feet of cannabis ready
production with its recently completed Phase 2 expansion. The
Company intends on expanding to 120,000 square feet by the end of
2018 once Phase 3 is complete.
Invictus also owns 50% of AB Laboratories Inc. ("AB
Labs"), a licensed producer under the ACMPR located in
Hamilton, Ontario. AB Labs
currently operates in a 16,000 square foot facility and recently
acquired a facility adjacent to the existing property that will
allow for a total of 56,000 square feet of cultivation space
expected to be ready for production by June
2018. During the first quarter of 2018 AB Labs submitted a
secondary license to Health Canada for a nearby property on 100
acres under the name AB Ventures Inc. ("AB Ventures").
Invictus has committed $5.5 million
in cash to AB Ventures to secure its 33 1/3 percent ownership and
allow AB Ventures to build its first 20,000 square foot facility on
the 100-acre property.
Combined, the licensed producers owned by Invictus expect to
have approximately 200,000 square feet of cannabis production
capacity by the end of 2018 and 520,000 square feet of cannabis
production capacity by the end of 2019.
In addition to the ACMPR licenses, the Company has an 82.5%
investment in Future Harvest Development Ltd. a high quality
Fertilizer and Nutrients manufacturer based in Kelowna, British Columbia that has been in
operation for over 20 years under the brand Plant Life Products and
Holland Secret.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,
Dan Kriznic
Chairman & CEO
Larry Heinzlmeir
Vice President, Marketing & Communications
604-537-8676
In the United States
Terry Wills
twills@willscom.com
310-877-1458
Cautionary Note Regarding Forward-Looking Statements: This
release includes certain statements and information that may
constitute forward-looking information within the meaning of
applicable Canadian securities laws or forward-looking statements
within the meaning of the United States Private Securities
Litigation Reform Act of 1995. All statements in this news release,
other than statements of historical facts, including statements
regarding future estimates, plans, objectives, timing, assumptions
or expectations of future performance, including the potential
production capacity of AB Labs, AB Ventures and Acreage Pharms, the
completion of AB Ventures and Acreage Pharms' production
facilities, the granting of regulatory approval and anticipated
timing of AB Labs reaching full production capacity, the granting
of AB Labs secondary license, the granting of a sales license under
the ACMPR to Acreage Pharms, expected sales of inventory and the
legalization of the recreational use of marijuana in Canada in 2018 are forward-looking statements
and contain forward-looking information. Generally, forward-looking
statements and information can be identified by the use of
forward-looking terminology such as "intends" or "anticipates", or
variations of such words and phrases or statements that certain
actions, events or results "may", "could", "should", "would" or
"occur". Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release, AB
Labs will be successful in reaching its potential production
capacity on the timeline expected by the Company, AB Ventures and
Acreage Pharms' production facilities will be completed as
anticipated, regulatory approval will be granted as anticipated, AB
Labs will reach full production capacity on the timeline
anticipated by the Company, AB Labs will be granted its secondary
license on the terms and timeline anticipated by the Company, no
unforeseen construction delays will be experienced, Acreage Pharms
will be granted its sales license under the ACMPR on the terms and
timeline anticipated by the Company, expected sales of inventory
will be met and the legalization of the recreational use of
marijuana in Canada will occur as
expected. These forward-looking statements are subject to
known and unknown risks, uncertainties and other factors that may
cause the actual results, level of activity, performance or
achievements of the Company to be materially different from those
expressed or implied by such forward-looking statements or
forward-looking information. Important factors that may cause
actual results to vary, include, without limitation, AB Labs will
not be successful in reaching its potential production capacity, AB
Ventures and Acreage Pharms' production facilities will not be
completed as anticipated, construction delays, regulatory approval
will not be granted as anticipated and therefore, the anticipated
timing of AB Labs reaching full production capacity will be
delayed, AB Labs not be granted their secondary license,
Acreage Pharms will not be granted its sales license under
the ACMPR, licenses or approvals being granted on terms or
timelines that are materially worse than expected by the Company,
expected sales of inventory will not be met and the legalization of
the recreational use of marijuana in Canada will not occur at all or as expected.
Although management of the Company has attempted to identify
important factors that could cause actual results to differ
materially from those contained in forward-looking statements or
forward-looking information, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can
be no assurance that such statements will prove to be accurate, as
actual results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not
place undue reliance on forward-looking statements and
forward-looking information. Readers are cautioned that reliance on
such information may not be appropriate for other purposes. The
Company does not undertake to update any forward-looking statement,
forward-looking information or financial out-look that are
incorporated by reference herein, except in accordance with
applicable securities laws. We seek safe harbor.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Invictus MD Strategies